| An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (NCT03338790) | Bristol-Myers Squibb | 2017-12-19 |
| Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine (NCT03303092) | Otsuka Pharmaceutical Co., Ltd. | 2017-12-19 |
| Lorcaserin in the Treatment of Cocaine Use Disorder (NCT03007394) | National Institute on Drug Abuse (NIDA) | 2017-12-19 |
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma (NCT03174275) | UNC Lineberger Comprehensive Cancer Center | 2017-12-19 |
| Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine (NCT03303079) | Otsuka Pharmaceutical Co., Ltd. | 2017-12-19 |
| Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease (NCT03304821) | Emory University | 2017-12-19 |
| Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder (NCT03299166) | Biohaven Pharmaceuticals, Inc. | 2017-12-19 |
| A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (NCT03292406) | Galderma R&D | 2017-12-19 |
| Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer (NCT03231176) | ASLAN Pharmaceuticals | 2017-12-19 |
| Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) (NCT03264989) | Novartis Pharmaceuticals | 2017-12-19 |
| Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer (NCT03308396) | Ajjai Alva, MD | 2017-12-19 |
| Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter (NCT03423979) | Urotronic Inc. | 2017-12-19 |
| Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy (NCT02949947) | M.D. Anderson Cancer Center | 2017-12-18 |
| A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer (NCT03336216) | Bristol-Myers Squibb | 2017-12-18 |
| A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) (NCT03144674) | Incyte Corporation | 2017-12-18 |
| Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip (NCT03382262) | Pacira Pharmaceuticals, Inc | 2017-12-18 |
| Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B (NCT03407651) | Catalyst Biosciences | 2017-12-18 |
| A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) (NCT03495882) | Agenus Inc. | 2017-12-18 |
| Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma (NCT03269552) | University of Washington | 2017-12-18 |
| A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH) (NCT03347188) | Teva Branded Pharmaceutical Products R&D, Inc. | 2017-12-18 |
| Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy (NCT03315364) | Daehwa Pharmaceutical Co., Ltd. | 2017-12-18 |
| Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy (NCT03334617) | AstraZeneca | 2017-12-18 |
| A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment (NCT03276975) | Duke University | 2017-12-18 |
| Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D (NCT03099785) | Cosmo Technologies Ltd | 2017-12-18 |
| A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) (NCT03367403) | Eli Lilly and Company | 2017-12-18 |
| Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma (NCT03336073) | PETHEMA Foundation | 2017-12-18 |
| Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure (NCT03200860) | University Medical Center Groningen | 2017-12-18 |
| Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression (NCT03050736) | Kintara Therapeutics, Inc. | 2017-12-17 |
| Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate (NCT03134846) | University Medical Center Groningen | 2017-12-16 |
| Tirofiban for Patients Treated With Alteplase (NCT03357133) | Capital Medical University | 2017-12-16 |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) (NCT03410030) | HonorHealth Research Institute | 2017-12-15 |
| Phase Ib Study of Chiauranib in Patients With Ovarian Cancer (NCT03166891) | Chipscreen Biosciences, Ltd. | 2017-12-15 |
| Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence (NCT03152903) | Serum Institute of India Pvt. Ltd. | 2017-12-15 |
| Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis (NCT03463187) | Jiangsu HengRui Medicine Co., Ltd. | 2017-12-15 |
| Add-on Methotrexate for the Treatment of Schizophrenia (NCT03369795) | Sheba Medical Center | 2017-12-15 |
| Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study (NCT03202667) | University Hospital, Basel, Switzerland | 2017-12-15 |
| Aspirin in Colorectal Cancer Liver Metastases (NCT03326791) | Oslo University Hospital | 2017-12-15 |
| CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT03110744) | University Hospital Heidelberg | 2017-12-15 |
| Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma (NCT03364608) | AstraZeneca | 2017-12-15 |
| Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma (NCT03317457) | AIO-Studien-gGmbH | 2017-12-15 |
| A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis (NCT03332225) | Hellenic Institute for the Study of Sepsis | 2017-12-15 |
| Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) (NCT03322540) | Incyte Corporation | 2017-12-15 |
| Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients (NCT03321188) | Andrea Jewell | 2017-12-15 |
| Effect of High Protein Diet in Stroke Patients With Low Muscle Mass (NCT04295044) | Chang Gung Memorial Hospital | 2017-12-15 |
| A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder (NCT03352453) | Naurex, Inc, an affiliate of Allergan plc | 2017-12-15 |
| Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy (NCT03344640) | Novartis Pharmaceuticals | 2017-12-15 |
| Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors (NCT03290079) | H. Lee Moffitt Cancer Center and Research Institute | 2017-12-15 |
| Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion (NCT03494816) | Scottish Clinical Trials Research Unit | 2017-12-15 |
| Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients (NCT01837277) | Fundação Bahiana de Infectologia | 2017-12-15 |
| Anti-Cytokine Therapy for Hemodialysis InflammatION (NCT03141983) | University of Pennsylvania | 2017-12-15 |
| A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors (NCT03311334) | Sumitomo Pharma America, Inc. | 2017-12-14 |
| Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial (NCT03259165) | Indiana University | 2017-12-14 |
| Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT) (NCT03315689) | Aclaris Therapeutics, Inc. | 2017-12-14 |
| A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis (NCT03341767) | University of Washington | 2017-12-14 |
| A Study Evaluating the Efficacy and Safety of HSK3486 (NCT03709056) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2017-12-14 |
| Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma (NCT03063632) | National Cancer Institute (NCI) | 2017-12-14 |
| Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure (NCT03415906) | Hannover Medical School | 2017-12-14 |
| Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer (NCT03190265) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-12-14 |
| Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis (NCT03315026) | Memorial Sloan Kettering Cancer Center | 2017-12-14 |
| Vorinostat (SAHA) in Uterine Sarcoma (NCT03509207) | Medical University of Graz | 2017-12-14 |
| Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients (NCT03280511) | Michael Bau Mortensen | 2017-12-14 |
| Effects of Salvinorin A on Brain Function (NCT03418714) | Johns Hopkins University | 2017-12-14 |
| Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes (NCT03222856) | MedSIR | 2017-12-14 |
| Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer (NCT03377400) | Samsung Medical Center | 2017-12-14 |
| Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) (NCT03345810) | AIO-Studien-gGmbH | 2017-12-14 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease (NCT03351738) | MedImmune LLC | 2017-12-13 |
| FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer (NCT03212170) | University of Wisconsin, Madison | 2017-12-13 |
| DAW1033D in Obstructive Sleep Apnea (NCT03383887) | Brigham and Women's Hospital | 2017-12-13 |
| Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD (NCT03461276) | Araclon Biotech S.L. | 2017-12-13 |
| Mechlorethamine Induced Contact Dermatitis Avoidance Study (NCT03380026) | Rochester Skin Lymphoma Medical Group, PLLC | 2017-12-13 |
| Entinostat Neuroendocrine (NE) Tumor (NCT03211988) | Antonio Fojo | 2017-12-13 |
| Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma (NCT03297593) | Swiss Cancer Institute | 2017-12-13 |
| Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer (NCT03377387) | Memorial Sloan Kettering Cancer Center | 2017-12-13 |
| Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant (NCT03386305) | Albert Einstein Healthcare Network | 2017-12-13 |
| Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer (NCT03088930) | University of Colorado, Denver | 2017-12-13 |
| Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin (NCT03161132) | Grupo Español de Investigación en Cáncer de Ovario | 2017-12-13 |
| Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma (NCT03358147) | Pearl Therapeutics, Inc. | 2017-12-13 |
| A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma (NCT03339219) | Takeda | 2017-12-13 |
| Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer (NCT03344172) | Nathan Bahary, MD | 2017-12-13 |
| Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (NCT03361748) | Celgene | 2017-12-13 |
| Efficacy and Safety of Low-dose Ticagrelor (NCT03381742) | First Affiliated Hospital of Harbin Medical University | 2017-12-13 |
| A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy (NCT03321526) | Janssen Research & Development, LLC | 2017-12-12 |
| CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer (NCT03285412) | Massachusetts General Hospital | 2017-12-12 |
| Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer (NCT03237377) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-12-12 |
| A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer (NCT03939871) | Chinese Academy of Medical Sciences | 2017-12-12 |
| First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b (NCT03319628) | Mersana Therapeutics | 2017-12-12 |
| A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy (NCT03326193) | Tesaro, Inc. | 2017-12-12 |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer (NCT03345420) | University of Utah | 2017-12-12 |
| A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan (NCT03485144) | Medigen Vaccine Biologics Corp. | 2017-12-12 |
| First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years (NCT03492775) | Prof. Dr. Wolfgang Hiddemann | 2017-12-12 |
| Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB (NCT03085758) | Adrenomed AG | 2017-12-12 |
| Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma (NCT03280667) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2017-12-12 |
| Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients (NCT03348683) | Icahn School of Medicine at Mount Sinai | 2017-12-11 |
| Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS (NCT03362294) | Mapi Pharma Ltd. | 2017-12-11 |
| Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib (NCT03592199) | Instituto do Cancer do Estado de São Paulo | 2017-12-11 |
| Modafinil for the Treatment of Alcohol Use Disorders (NCT03424681) | The Mind Research Network | 2017-12-11 |
| Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer. (NCT03119519) | Southern Medical University, China | 2017-12-11 |
| NEPHSTROM for Diabetic Kidney Disease (NCT02585622) | Mario Negri Institute for Pharmacological Research | 2017-12-11 |
| Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma (NCT03318497) | University of Texas Southwestern Medical Center | 2017-12-11 |
| Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis (NCT03392168) | Arcutis Biotherapeutics, Inc. | 2017-12-11 |